Literature DB >> 8268613

A new procedure for the removal of protein bound drugs and toxins.

J Stange, S Mitzner, W Ramlow, T Gliesche, H Hickstein, R Schmidt.   

Abstract

To extend the applicability of dialysis to the removal of albumin bound toxins, a new dialysis procedure was developed. A double sided albumin impregnated high-flux polysulfon dialyzer was used together with a closed loop dialysate compartment with an albumin containing dialysate solution, that was purified on line in a three step process with a charcoal and resin adsorbent, and another dialyzer for a normal dialysis or filtration of the albumin containing dialysate that was then recycled to the albumin impregnated dialyzer. The system effectively removed strongly albumin bound toxins like unconjugated bilirubin or free fatty acids from plasma and blood in vitro and in vivo and therefore could be considered a possible therapeutic means for the treatment of acute liver failure or acute and chronic intoxications with albumin bound toxins, e.g., in drug overdose or chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268613

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  15 in total

Review 1.  Treatment of acute liver failure.

Authors:  K H Boeker
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 2.  Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS--a review of clinical, biochemical, and electrophysiological data.

Authors:  S Mitzner; J Loock; P Peszynski; S Klammt; J Majcher-Peszynska; A Gramowski; J Stange; R Schmidt
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

3.  Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure.

Authors:  Taru Kantola; Suvi Mäklin; Anna-Maria Koivusalo; Pirjo Räsänen; Anne Rissanen; Risto Roine; Harri Sintonen; Krister Höckerstedt; Helena Isoniemi
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 4.  Prospects for extracorporeal liver support.

Authors:  R Jalan; S Sen; R Williams
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

5.  Preoperative risk factor analysis in orthotopic liver transplantation with pretransplant artificial liver support therapy.

Authors:  Jin-Zhong Yuan; Qi-Fa Ye; Ling-Ling Zhao; Ying-Zi Ming; Hong Sun; Shai-Hong Zhu; Zu-Fa Huang; Min-Min Wang
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

6.  Removal selectivity of Prometheus: a new extracorporeal liver support device.

Authors:  Kinan Rifai; Thomas Ernst; Ulrich Kretschmer; Hermann Haller; Michael Peter Manns; Danilo Fliser
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

7.  Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience.

Authors:  Cataldo Doria; Lucio Mandalá; Victor L Scott; Salvatore Gruttadauria; Ignazio R Marino
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 8.  Extracorporeal liver support.

Authors:  Jan Stange
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

9.  Extracellular brain ammonia levels in association with arterial ammonia, intracranial pressure and the use of albumin dialysis devices in pigs with acute liver failure.

Authors:  Kerstin Zwirner; Christian Thiel; Karolin Thiel; Matthias H Morgalla; Alfred Königsrainer; Martin Schenk
Journal:  Metab Brain Dis       Date:  2010-11-18       Impact factor: 3.584

10.  Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs.

Authors:  Sambit Sen; Lars M Ytrebø; Christopher Rose; Ole-Martin Fuskevaag; Nathan A Davies; Geir I Nedredal; Roger Williams; Arthur Revhaug; Rajiv Jalan
Journal:  Intensive Care Med       Date:  2004-01-21       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.